New surgery for keratoconus: will it sharpen vision and daily life?
NCT ID NCT07474870
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will follow 100 people with keratoconus or corneal ectasia who undergo CTAK surgery. Researchers will use a questionnaire before and after surgery to measure changes in vision quality and overall quality of life. The goal is to see if this surgical approach helps patients see better and feel better day-to-day.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Corneal tissue addition surgery (CTAK)
- What this could lead to
- If successful, this could show that CTAK surgery improves vision and quality of life for people with keratoconus.
- What could go wrong
- This is a small, early-stage study (100 people) that only measures outcomes, not comparing to other treatments. Results may not apply to everyone with corneal ectasia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL ECTASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Byers Eye Institute at Stanford
Palo Alto, California, 94303, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple eyeglass test sharpen vision in keratoconus?
- Can a donor corneal lenticule patch up a thinning cornea?
- A piece of your own cornea might patch a thinning one — a trial puts it to the test
- Can a simple eye treatment stop the need for a corneal transplant?
- Eye insert could ease allergy symptoms for contact lens wearers
- Promising new eye treatment could halt vision loss from keratoconus